share_log

Agile Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer Welsh Amy

SEC ·  Jun 30, 2023 16:38
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more